PERCEPTIVE ADVISORS LLC

CIK 1224962 · View on SEC EDGAR ↗

Portfolio value
$6.7B
#663 of 9,443 by 13F value · top 7.0%
Positions
109
As of
June 30, 2026

Portfolio value QoQ: +30.2% 13F does not disclose cash

Top 10 holdings weight
47.30%
Top 25 holdings weight
75.10%
Positions above 1%
26
Effective number of positions
30.2

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q2 2026: 18.13% Est. buys $1,573,338,305 · sells $1,067,858,895

Median holding: 3.0 quarters Tracked Q4 2024–Q2 2026 · 50.2% still held

New positions
29
Increased
30
Decreased
26
Closed
14

Put-notional exposure: 3.0% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets

On this page

Performance vs S&P 500

Tracked Q4 2024–Q2 2026
+101.6%
S&P 500 total return (same window)
+28.1%
Excess return
+73.5%

Annualized: +59.8% · S&P 500: +18.0%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 97.0% · Options excluded: 1.3%

Sector breakdown

Healthcare
89.0%
Financials
0.2%
Other/Unmapped
10.8%

Full portfolio 109 positions

Type Streak 8Q trend
PRAX Praxis Precision Medicines, Inc. - Common Stock $681,627,753 10.23% 2,035,986 $25,653,424
SYRE Spyre Therapeutics, Inc. - Common Stock $383,484,855 5.76% 4,319,496 $192,658,986 Up ×3
CELC Celcuity Inc. - Common Stock $334,491,064 5.02% 3,197,200 $-22,447,544 Up ×1
Unknown issuer (CUSIP: K08588103) $310,387,665 4.66% 1,163,721 Up ×1
RYTM Rhythm Pharmaceuticals, Inc. - Common Stock $287,156,334 4.31% 2,586,295 $80,707,383 Up ×1
ROIV Roivant Sciences Ltd. - Common Shares $286,144,465 4.30% 8,085,461 $56,637,195 Down ×1
RLAY Relay Therapeutics, Inc. - Common Stock $263,926,759 3.96% 14,106,187 $166,902,906 Up ×2
TVTX Travere Therapeutics, Inc. - Common Stock $213,183,729 3.20% 3,752,574 $90,108,539 Down ×2
Unknown issuer (CUSIP: 485925101) $195,585,788 2.94% 8,200,662 Up ×1
NUVL Nuvalent, Inc. - Class A Common Stock $195,192,368 2.93% 1,580,505 $33,269,631
EWTX Edgewise Therapeutics, Inc. - Common Stock $177,714,564 2.67% 4,373,974 $38,359,383 Down ×2
APGE Apogee Therapeutics, Inc. - Common Stock $173,625,838 2.61% 1,308,113 $43,971,717 Down ×2
AMLX Amylyx Pharmaceuticals, Inc. - Common Stock $149,694,481 2.25% 8,334,882 $34,534,621 Up ×1
MGTX MeiraGTx Holdings plc - Ordinary Shares $145,727,749 2.19% 10,786,658 $56,414,885 Up ×1
ORKA Oruka Therapeutics, Inc. - Common Stock $128,009,646 1.92% 1,345,063 $59,560,322 Down ×2
INBX Inhibrx Biosciences, Inc. - Common Stock $122,963,044 1.85% 1,297,763 $25,969,852 Down ×2
PTGX Protagonist Therapeutics, Inc. - Common Stock $120,358,728 1.81% 981,879 $-9,375,919 Down ×2
SLDB Solid Biosciences Inc. - Common Stock $118,947,393 1.79% 11,906,646 $33,219,542
ZYME Zymeworks Inc. - Common Stock $109,342,391 1.64% 4,182,953 $21,450,038 Up ×4
TNGX Tango Therapeutics, Inc. - Common Stock $105,565,020 1.58% 3,377,000 $88,658,459 Up ×2
IMTX Immatics N.V. - Ordinary Shares $105,184,409 1.58% 10,383,456 $3,011,202
NRIX Nurix Therapeutics, Inc. - Common stock $104,813,438 1.57% 4,320,422 $47,294,844 Up ×5
BCRX BioCryst Pharmaceuticals, Inc. - Common Stock $103,088,880 1.55% 10,308,888 $32,316,886 Up ×2
RVMD Revolution Medicines, Inc. - Common Stock $98,808,928 1.48% 527,600 $73,660,078 Up ×1
Unknown issuer (CUSIP: 05348Y105) $88,070,744 1.32% 2,675,296 Up ×1
MRNA Moderna, Inc. - Common Stock $70,030,000 1.05% 1,000,000 Put option $19,230,000
DYN Dyne Therapeutics, Inc. - Common Stock $59,727,909 0.90% 2,689,235 $-24,918,142 Down ×1
BIIB Biogen Inc. - Common Stock $59,669,938 0.90% 276,173
IMVT Immunovant, Inc. - Common Stock $52,299,967 0.79% 1,357,383 $12,620,973 Down ×2
UNH UnitedHealth Group Incorporated Common Stock (DE) $48,548,078 0.73% 116,806 Up ×1
XBI XBI $47,475,000 0.71% 300,000 Put option
IONS Ionis Pharmaceuticals, Inc. - Common Stock $44,878,140 0.67% 566,000 $7,032,780 Up ×1
STRO Sutro Biopharma, Inc. - Common Stock $43,320,887 0.65% 1,304,846 $25,502,590 Up ×1
ANRO Alto Neuroscience, Inc. Common Stock $42,485,076 0.64% 1,609,893 $-2,697,319 Down ×1
JAZZ Jazz Pharmaceuticals plc - Ordinary Shares $40,964,900 0.61% 170,000 $8,826,400
CRVS Corvus Pharmaceuticals, Inc. - Common Stock $39,851,569 0.60% 2,667,441 $6,313,157 Up ×2
SION Sionna Therapeutics, Inc. - Common Stock $39,810,950 0.60% 905,000 $13,414,130 Up ×1
CTMX CytomX Therapeutics, Inc. - Common Stock $39,146,944 0.59% 10,439,185 $-8,317,529 Up ×2
AORT Artivion, Inc. Common Stock $39,036,906 0.59% 1,737,290 $-20,920,654 Up ×1
XFOR X4 Pharmaceuticals, Inc. - Common Stock $37,049,403 0.56% 7,933,491 $9,222,917 Up ×2
CORT Corcept Therapeutics Incorporated - Common Stock $34,639,576 0.52% 398,385 $32,624,076 Up ×1
RGEN Repligen Corporation - Common Stock $33,866,045 0.51% 248,212 $812,704 Down ×2
AVR Anteris Technologies Global Corp. - Common Stock $33,740,939 0.51% 3,425,476 $14,729,547
RAPP Rapport Therapeutics, Inc. - Common Stock $32,225,161 0.48% 773,342 $11,138,110 Up ×1
GLTO Galecto, Inc. - Common Stock $31,810,230 0.48% 1,223,000 $134,530
CRL Charles River Laboratories International, Inc. Common Stock $31,750,600 0.48% 140,000
AXSM Axsome Therapeutics, Inc. - Common Stock $28,993,007 0.44% 118,450 $3,648,458 Down ×1
EYPT EyePoint, Inc. - Common Stock $28,600,000 0.43% 2,000,000 Put option Up ×1
DBVT DBV Technologies S.A. - American Depositary Shares $27,114,940 0.41% 1,653,350 $6,968,812 Up ×1
IRTC iRhythm Holdings, Inc. - Common Stock $26,616,966 0.40% 223,766 $14,221,797 Up ×1
ADPT Adaptive Biotechnologies Corporation - Common Stock $26,111,621 0.39% 1,217,325 $23,994,921 Up ×1
SABS SAB Biotherapeutics, Inc. - Common Stock $25,847,254 0.39% 6,627,501 $1,213,678 Up ×2
DHR Danaher Corporation Common Stock $24,762,400 0.37% 130,000
TENX Tenax Therapeutics, Inc. - Common Stock $24,735,000 0.37% 1,700,000 $1,584,966 Up ×2
CAPR Capricor Therapeutics, Inc. - Common Stock $24,080,000 0.36% 1,000,000 Call option
SLS SELLAS Life Sciences Group, Inc. - Common Stock $22,140,000 0.33% 1,500,000 Put option Up ×1
NAUT Nautilus Biotechnology, Inc. - Common Stock $21,755,974 0.33% 11,634,211 $-27,109,564 Down ×1
OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares $21,738,564 0.33% 5,037,906 $327,463
ISRG Intuitive Surgical, Inc. - Common Stock $20,633,229 0.31% 51,884 $-18,744,076 Down ×2
ANL Adlai Nortye Ltd. - American Depositary Shares $20,621,685 0.31% 1,793,190 Up ×1
CTNM Contineum Therapeutics, Inc. - Common stock $20,579,153 0.31% 1,255,592 $4,181,121
NVCT Nuvectis Pharma, Inc. - Common Stock $18,390,000 0.28% 1,000,000 Up ×1
PALI Palisade Bio, Inc. - Common Stock $17,608,386 0.26% 8,425,065 $1,984,125 Down ×2
OMDA Omada Health, Inc. - Common Stock $17,259,943 0.26% 786,330 $7,375,775
LONA LeonaBio, Inc. - Common Stock $17,087,169 0.26% 1,859,322 $-2,026,661
EOLS Evolus, Inc. - Common Stock $17,067,438 0.26% 2,459,285 $11,778,435 Up ×1
NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares $16,945,000 0.25% 500,000 Put option Up ×1
IVVD Invivyd, Inc. - Common Stock $16,131,231 0.24% 18,490,636 $-10,985,863 Down ×2
Unknown issuer (CUSIP: 15102KAA8) $14,629,442 0.22% 6,500,000 $-1,246,332
MIRM Mirum Pharmaceuticals, Inc. - common stock $13,508,824 0.20% 115,391
SRZN Surrozen, Inc. - Common Stock $13,078,411 0.20% 503,985 $6,396,193 Up ×1
BBNX Beta Bionics, Inc. - Common Stock $13,052,232 0.20% 832,944 $4,605,933 Down ×1
CAPR Capricor Therapeutics, Inc. - Common Stock $12,040,000 0.18% 500,000 Put option
AXGN Axogen, Inc. - Common Stock $11,423,341 0.17% 247,312 $-11,678,606 Down ×2
OSCR Oscar Health, Inc. Class A Common Stock $11,408,000 0.17% 400,000 Up ×1
OCS Oculis Holding AG - Ordinary shares $11,218,430 0.17% 808,827 $-1,912,430 Up ×1
Unknown issuer (CUSIP: 81221K108) $10,860,000 0.16% 500,000 Up ×1
VRDN Viridian Therapeutics, Inc. - Common Stock $10,690,973 0.16% 581,980 $-12,210,442 Down ×2
BSX Boston Scientific Corporation Common Stock $10,670,000 0.16% 250,000
BLLN BillionToOne, Inc. - Class A common stock $10,415,704 0.16% 86,812 $3,168,065 Down ×1
ABVX Abivax SA - American Depositary Shares $9,861,240 0.15% 74,000 $-26,759,993 Down ×2
NTRA Natera, Inc. - Common Stock $9,416,329 0.14% 34,689
Unknown issuer (CUSIP: 29286X101) $8,342,352 0.13% 4,822,169 Up ×1
Unknown issuer (CUSIP: G75226103) $8,025,000 0.12% 750,000 Up ×1
AGMB AgomAb Therapeutics NV - ADRs representing one common share. $7,788,000 0.12% 600,000 $1,494,000
CGEM Cullinan Therapeutics, Inc. - Common Stock $7,766,164 0.12% 426,478
QURE uniQure N.V. - Ordinary Shares $7,738,080 0.12% 168,000
Unknown issuer (CUSIP: 60705V103) $7,016,963 0.11% 523,654 Up ×1
ADGM Adagio Medical Holdings, Inc - Common Stock $6,439,534 0.10% 9,876,586 $-4,572,848 Up ×1
GH Guardant Health, Inc. - Common Stock $6,200,290 0.09% 41,327 $-21,510,710 Down ×1
PHAT Phathom Pharmaceuticals, Inc. - Common Stock $5,772,200 0.09% 532,000 $-4,504,550 Down ×1
OTLK Outlook Therapeutics, Inc. - Common Stock $4,991,353 0.07% 3,139,216 Up ×1
COGT Cogent Biosciences, Inc. - Common Stock $4,685,873 0.07% 121,082 $25,427
EDSA Edesa Biotech, Inc. - Common Shares $4,579,133 0.07% 563,239 $1,633,393
AVTX Avalo Therapeutics, Inc. - Common Stock $4,062,144 0.06% 219,813 $1,976,916 Up ×1
TWST Twist Bioscience Corporation - Common Stock $3,787,219 0.06% 36,812 $-3,340,781 Down ×1
CBIO Crescent Biopharma, Inc. - Common Stock $3,724,956 0.06% 206,942 $-76,569
XERS Xeris Biopharma Holdings, Inc. - Common Stock $3,698,743 0.06% 467,013 Up ×1
OM Outset Medical, Inc. - Common Stock $3,599,998 0.05% 833,333 $400,000
BDSX Biodesix, Inc. - Common Stock $2,451,049 0.04% 108,694

Conviction holdings

Positions increased for 3+ consecutive quarters.

Share counts are as reported in 13F filings (not split-adjusted)

Security Value % of portfolio Streak
SYRE $383,484,855 5.76% up ×3
ZYME $109,342,391 1.64% up ×4
NRIX $104,813,438 1.57% up ×5

Biggest new bets

New positions opened this quarter, largest first.

Security Value Shares % of portfolio
Unknown issuer (CUSIP: K08588103) $310,387,665 1,163,721 4.66%
Unknown issuer (CUSIP: 485925101) $195,585,788 8,200,662 2.94%
Unknown issuer (CUSIP: 05348Y105) $88,070,744 2,675,296 1.32%
BIIB $59,669,938 276,173 0.90%
UNH $48,548,078 116,806 0.73%
XBI $47,475,000 300,000 0.71%
CRL $31,750,600 140,000 0.48%
EYPT $28,600,000 2,000,000 0.43%
DHR $24,762,400 130,000 0.37%
CAPR $24,080,000 1,000,000 0.36%
SLS $22,140,000 1,500,000 0.33%
ANL $20,621,685 1,793,190 0.31%
NVCT $18,390,000 1,000,000 0.28%
NAMS $16,945,000 500,000 0.25%
MIRM $13,508,824 115,391 0.20%

Top movers (QoQ)

Security Action Shares Δ Value Δ
SYRE Bought more +536K +$192.7M
RLAY Bought more +4.4M +$166.9M
TVTX Trimmed -390K +$90.1M
RYTM Bought more +212K +$80.7M
RVMD Bought more +269K +$73.7M
ORKA Trimmed -50K +$59.6M
ROIV Trimmed -200K +$56.6M
MGTX Bought more +461K +$56.4M
NRIX Bought more +610K +$47.3M
APGE Trimmed -232K +$44.0M

1 position hidden (data completeness check)

Exited positions

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarter Shares before Value before Price since exit
ASND June 30, 2026 1,531,421 $350,281,925 -4.0%
CNTA June 30, 2026 5,258,903 $208,883,627 No longer tracked
XBI March 31, 2026 1,100,000 $134,123,000 No longer tracked
MRUS Dec. 31, 2025 1,353,093 $127,393,706 No longer tracked
EXAS March 31, 2026 1,200,487 $121,921,460 No longer tracked
ITCI June 30, 2025 786,358 $103,736,347 No longer tracked
INSM Dec. 31, 2025 702,130 $101,113,741 -26.0%
ACLX March 31, 2026 1,466,071 $95,587,829 No longer tracked
BSX March 31, 2026 979,000 $93,347,650 -17.8%
FOLD March 31, 2026 6,370,851 $90,720,918 No longer tracked
ATXS March 31, 2026 6,485,420 $84,894,147 No longer tracked
VRNA Dec. 31, 2025 524,088 $55,925,430 No longer tracked
AKRO Dec. 31, 2025 1,135,766 $53,926,170 No longer tracked
DHR March 31, 2026 200,000 $45,784,000 10.9%
IOVA June 30, 2025 12,711,788 $42,330,254 342.7%
ENGN June 30, 2026 5,827,506 $39,685,316 1.2%
DAWN June 30, 2026 1,755,799 $37,644,331 No longer tracked
CDTX March 31, 2026 165,131 $36,475,787 No longer tracked
SLNO Sept. 30, 2025 430,439 $36,062,179 No longer tracked
IRON March 31, 2026 450,743 $35,793,502 26.5%
ARGX June 30, 2025 59,510 $35,221,886 85.0%
PEN March 31, 2026 110,529 $34,364,571 -0.5%
CAI March 31, 2026 1,136,206 $30,654,838 25.8%
RAPT March 31, 2026 825,890 $27,972,894 No longer tracked
PVLA March 31, 2026 266,287 $27,872,260 20.8%
DRUG June 30, 2026 377,544 $27,549,386 21.6%
PCVX June 30, 2025 706,567 $26,679,970 91.4%
XBI Sept. 30, 2025 300,000 $24,879,000 No longer tracked
BLTE June 30, 2026 151,979 $24,231,532 7.2%
KOD March 31, 2026 848,900 $23,735,244 6.9%
PRCT March 31, 2025 290,659 $23,403,863 -62.5%
EOLS Sept. 30, 2025 2,474,843 $22,793,304 36.1%
BIIB March 31, 2026 124,000 $21,822,760 19.3%
ALDX March 31, 2026 4,185,632 $21,681,574 -7.6%
MIRM March 31, 2026 259,545 $20,501,460 11.0%
GRAL March 31, 2026 237,342 $20,314,102 46.7%
NTRA March 31, 2025 125,000 $19,787,500 122.9%
PODD Sept. 30, 2025 60,387 $18,972,388 -50.7%
CVS March 31, 2026 220,000 $17,459,200 33.2%
PEN March 31, 2025 73,338 $17,416,308 22.1%
SEPN March 31, 2025 750,000 $17,175,000 660.1%
ORKA March 31, 2025 845,567 $16,395,544 967.5%
GKOS March 31, 2026 140,000 $15,807,400 74.0%
MDGL June 30, 2025 46,500 $15,402,195 76.8%
CRL Sept. 30, 2025 100,000 $15,173,000 85.4%
DXCM March 31, 2026 225,758 $14,983,558 45.4%
SVRA March 31, 2026 2,400,000 $14,472,000 0.0%
ARVN March 31, 2025 740,749 $14,200,158 36.6%
DXCM June 30, 2025 178,000 $12,155,620 4.6%
SEPN March 31, 2026 433,160 $12,076,501 83.1%
CGON March 31, 2025 419,450 $12,029,826 220.5%
ACRV June 30, 2025 5,360,858 $10,882,542 75.7%
EW March 31, 2025 145,000 $10,734,350 27.6%
TARS March 31, 2025 186,662 $10,335,475 41.0%
EVMN June 30, 2026 448,350 $10,307,567 10.7%
NMRA June 30, 2026 5,104,097 $9,952,989 -2.4%
CRGX June 30, 2025 2,431,085 $9,894,515 No longer tracked
RARE Sept. 30, 2025 270,000 $9,817,200 -12.2%
GOSS March 31, 2026 3,139,669 $9,732,974 -53.5%
MPLT March 31, 2026 550,000 $9,660,750 -41.9%
CRNX March 31, 2025 184,525 $9,434,763 152.7%
NARI March 31, 2025 178,797 $9,127,587 No longer tracked
XENE March 31, 2026 200,791 $8,999,453 10.0%
NBIX June 30, 2026 65,050 $8,569,687 -7.8%
IRD June 30, 2026 1,835,842 $8,353,081 -5.6%
EYPT June 30, 2025 1,537,274 $8,332,025 -36.7%
KMTS March 31, 2026 285,000 $7,558,200 43.4%
CAPR Sept. 30, 2025 750,000 $7,447,500 6.8%
IRON June 30, 2025 150,000 $7,446,000 52.7%
JANX Dec. 31, 2025 292,686 $7,153,246 25.4%
CAPR March 31, 2026 242,100 $6,987,006 -74.7%
ADPT June 30, 2025 930,972 $6,917,122 119.7%
TEM Dec. 31, 2025 85,000 $6,860,350 -5.7%
OCUL June 30, 2025 915,775 $6,712,631 23.2%
ZBIO March 31, 2025 744,035 $6,093,647 300.6%
DCTH June 30, 2025 462,422 $5,886,632 26.5%
IRTC March 31, 2025 65,153 $5,874,846 13.2%
BHVN March 31, 2026 500,000 $5,645,000 69.9%
RAPP March 31, 2025 311,551 $5,526,915 391.6%
KYMR March 31, 2026 69,935 $5,441,642 49.0%
PEPG March 31, 2026 829,870 $5,402,454 63.8%
GMED Sept. 30, 2025 88,500 $5,223,270 54.1%
TECX March 31, 2026 250,000 $5,215,000 18.2%
HTFL Dec. 31, 2025 150,000 $5,049,000 59.5%
KMTS June 30, 2025 200,000 $4,984,000 72.4%
AQST March 31, 2026 747,193 $4,826,867 7.9%
CBLL March 31, 2025 180,546 $4,672,530 30.3%
OKUR June 30, 2025 1,004,439 $4,319,088 82.0%
KRYS March 31, 2026 17,500 $4,314,450 30.8%
OCUL June 30, 2026 500,000 $4,235,000 16.4%
HLXB Sept. 30, 2025 398,000 $4,226,760 No longer tracked
VERUXXXX March 31, 2025 6,483,157 $4,217,294 No longer tracked
OLMA March 31, 2026 165,713 $4,142,825 -25.6%
IKT June 30, 2026 2,315,000 $3,889,200 22.9%
CATX March 31, 2025 1,190,263 $3,796,939 No longer tracked
LCTX March 31, 2025 7,236,843 $3,636,514 No longer tracked
SDGR March 31, 2026 202,400 $3,618,912 69.1%
SCPH Dec. 31, 2025 583,142 $3,306,415 No longer tracked
APLS June 30, 2026 80,956 $3,256,860 No longer tracked
PEPG March 31, 2025 829,536 $3,143,941 106.4%
IBRX March 31, 2025 1,221,734 $3,127,639 167.1%
VKTX Dec. 31, 2025 105,597 $2,775,089 -1.8%
BCYC March 31, 2025 197,108 $2,759,512 -51.4%
PYXS Dec. 31, 2025 1,178,307 $2,615,842 193.9%
VRCA March 31, 2025 3,249,669 $2,274,768 13.6%
FBRX March 31, 2025 95,742 $2,174,301 891.4%
SPRY Dec. 31, 2025 200,000 $2,010,000 -43.9%
MREO June 30, 2025 876,961 $1,973,162 -88.7%
TRIB Dec. 31, 2025 1,790,000 $1,861,600 1426.6%
IMMX March 31, 2026 338,941 $1,772,661 38.3%
ATHA Sept. 30, 2025 5,402,964 $1,631,695 No longer tracked
LYRAXXXX June 30, 2025 12,757,562 $1,607,453 No longer tracked
TRIB March 31, 2025 1,790,000 $1,575,200 2015.8%
LYRA Dec. 31, 2025 229,382 $1,497,864 No longer tracked
LXEO March 31, 2026 139,835 $1,388,562 -7.4%
QURE Dec. 31, 2025 20,000 $1,167,400 97.2%
FULC March 31, 2025 238,000 $1,118,600 36.3%
PTN June 30, 2026 61,945 $1,079,082 -3.6%
TRAW June 30, 2025 421,781 $970,096 -62.6%
RCKT June 30, 2025 140,726 $938,642 44.7%
FBRX Sept. 30, 2025 68,192 $881,723 412.9%
NVAX March 31, 2025 100,000 $804,000 33.2%
LENZ March 31, 2026 50,000 $800,000 -45.5%
BDSX March 31, 2026 108,694 $739,119 61.2%
BDSXXXXX Sept. 30, 2025 2,173,880 $613,034 No longer tracked
CGEM June 30, 2025 80,100 $606,357 187.9%
NVNO March 31, 2026 1,759,035 $564,298 8.9%
APLT June 30, 2025 860,000 $420,454 No longer tracked
IOVA March 31, 2026 152,714 $416,909 117.0%
NBTX June 30, 2025 105,053 $376,090 812.9%
APYX Dec. 31, 2025 150,000 $321,000 -7.7%
PYXS March 31, 2025 188,462 $294,001 244.9%
KALA Sept. 30, 2025 55,227 $262,881 -41.8%